..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Ximelagatran Melagatran P-selectin Endogenous thrombin potential Atrial...

... thrombin inhibitors are being developed. The combined use of subcutaneous and oral administration of melagatran in patients with hip or knee replacement has led to promising results. It is likely that in the future thrombin inhibitors will replace other forms of anticoagulation in a number of indications...